3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application
Advanced Materials · 2025
DOI: 10.1002/adma.202501994 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, 2025. Verfasst von Francisco Branco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, Coimbra, 3000-548, Portugal. Hauptthemen laut MEDLINE: Glioblastoma, Bioprinting, Printing, Three-Dimensional, Brain Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 271 Literaturangaben. Gefördert von: Fundação para a Ciência e a Tecnologia, Coimbra Chemistry Centre, Santander Universities.
Abstract (Originalsprache)
Conventional in vitro models fail to accurately mimic the tumor in vivo characteristics, being appointed as one of the causes of clinical attrition rate. Recent advances in 3D culture techniques, replicating essential physical and biochemical cues such as cell–cell and cell–extracellular matrix interactions, have led to the development of more realistic tumor models. Bioprinting has emerged to advance the creation of 3D in vitro models, providing enhanced flexibility, scalability, and reproducibility. This is crucial for the development of more effective drug treatments, and glioblastoma (GBM) is no exception. GBM, the most common and deadly brain cancer, remains a major challenge, with a median survival of only 15 months post‐diagnosis. This review highlights the key components needed for 3D bioprinted GBM models. It encompasses an analysis of natural and synthetic biomaterials, along with crosslinking methods to improve structural integrity. Also, it critically evaluates current 3D bioprinted GBM models and their integration into GBM‐on‐a‐chip platforms, which hold noteworthy potential for drug screening and personalized therapies. A versatile development framework grounded on Quality‐by‐Design principles is proposed to guide the design of bioprinting models. Future perspectives, including 4D bioprinting and machine learning approaches, are discussed, along with the current gaps to advance the field further.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, Coimbra, 3000-548, Portugal.
- Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Faculty of Sciences and Technology, University of Coimbra, Coimbra, 3004-535, Portugal.
ORCID-Profile: Carla Vitorino
Förderung
- Fundação para a Ciência e a Tecnologia
- Coimbra Chemistry Centre
- Santander Universities
Zitieren
APA
Branco, F., Cunha, J., Mendes, M., Sousa, J. J., & Vitorino, C. (2025). 3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application. Advanced Materials. https://doi.org/10.1002/adma.202501994
Vancouver
Branco F, Cunha J, Mendes M, Sousa JJ, Vitorino C. 3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application. Advanced Materials. 2025. doi:10.1002/adma.202501994
BibTeX
@article{Branco2025,
author = {Branco, Francisco and Cunha, Joana and Mendes, Maria and Sousa, João J and Vitorino, Carla},
title = {3D Bioprinting Models for Glioblastoma: From Scaffold Design to Therapeutic Application},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202501994}
}
EUVIMED